Mariolla Dolleris Schroll

Mariolla Dolleris Schroll is a seasoned professional in the medical cannabis industry and business development, currently serving as the Chairman of the MCI board since 2023, following roles as Vice Chairman and board member from 2019 to 2022. As the Public Relations Officer at Schroll Medical ApS since 2018, Mariolla has advocated for the regulatory interests of the medical cannabis sector in Denmark, focusing on enhancing the legislative framework for the production of high-quality EU GMP products. Additionally, as a professional in business development at Schroll-flowers since 2013, notable work includes trademark applications and achieving several US plant patents. Previous experience includes roles as Senior Project Business Analyst and Business Consultant at ALOC A/S, and Business Analyst and System Developer at Aloc Bonnier A/S, with a solid educational background in Mathematics-Economics and Banking and Financial Support Services from the University of Southern Denmark.